Novel strategies to eradicate resistant cells in chronic myeloid leukemia

Future Med Chem. 2020 Dec;12(23):2089-2092. doi: 10.4155/fmc-2020-0278. Epub 2020 Nov 24.
No abstract available

Keywords: cancer stem cells (CSCs); cell death modulators; chronic myeloid leukemia (CML); sensitizers; therapy resistance; tyrosine kinase inhibitor (TKI).

Publication types

  • Editorial
  • Review

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Drug Resistance, Neoplasm / drug effects
  • Fusion Proteins, bcr-abl / antagonists & inhibitors
  • Fusion Proteins, bcr-abl / metabolism
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Neoplastic Stem Cells / drug effects*

Substances

  • Antineoplastic Agents
  • Fusion Proteins, bcr-abl